Connecting scientific advances with scalable manufacturing, rigorous evidence, and regulatory strategies can help bring therapies to patients.
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- Your 7 Decisions To Make Before MES Configuration
- Complete Response Letters For CGTs Share This Common Theme
- Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers
- DEA Reveals Hidden Costs Of Analytical Validation Guidelines
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters
- CDMO Selection Beyond Capabilities And Price
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Immunohistochemistry In Precision Medicine: From Biomarker To Clinical Trial Assay
From preclinical validation to clinical implementation, immunohistochemistry (IHC) is essential in understanding target biology and ensuring drug safety and efficacy.
-
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems
For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.
-
How To Take Your Process To A Closed System
Understand the critical considerations for implementing closed systems in bioproduction, from vessel selection to workflow customization for optimal efficiency and safety.
-
Alerion Microbubble Cell Separation System Used For T Cell Negative Selection
Discover how the Alerion™ Microbubble Cell Separation System outperformed standard magnetic methods in T cell recovery, speed, and scalability — achieving higher cell quality with Akadeum’s innovative microbubble technology.
-
CRISPR Reagents Enable High Efficiencies Of Editing And HDR In iPSCs
Achieving consistent Homology Directed Repair (HDR) in iPSCs requires optimized CRISPR design and workflows. See how advanced reagents and targeted enhancement strategies improve insertion efficiency.
-
Case Study: Full Clonality Assessment Of CHO Cell Line
In this case study, a comprehensive genetic analysis was performed on a transgenic Chinese hamster ovary (CHO) master cell bank to characterize the bank and provide high-confidence evidence of clonality.
-
Addressing Plasmid DNA Challenges In Large-Scale AAV And Lentivirus Manufacturing Using dbDNA
Plasmid DNA supply and regulatory concerns constrain large-scale viral vector manufacturing. Here, we examine whether enzymatically generated dbDNA can deliver comparable rAAV and rLV production outcomes.
-
Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment Landscape
See how rapid site activation, strong oncology site relationships, and adaptive protocol management kept a complex global cancer trial on track amid evolving standards of care.
-
Reshoring Pressure Meets Manufacturing Reality
U.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.
-
Fluorescent Bacterial Colony Selection
Fluorescent reporter genes simplify screening bacterial transformants. Discover a system that automates colony picking to enhance efficiency and precision with fluorescence imaging.
NEWSLETTER ARCHIVE
- 10.19.26 -- August 2026 — CDMO Opportunities And Threats Report
- 10.16.26 -- Manufacturing Solutions For Scalable Cell Therapy Production
- 10.16.26 -- Traversing Complexity In Breast Cancer Clinical Development
- 10.15.26 -- Your Vector Is Deciding The Path Of Your Cell & Gene Therapy Program
- 10.15.26 -- Which Viral Clearance Step Delivers The Highest LRV?
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections
